NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
October 8, 2025 — Ocumetics reports promising one-month results for revolutionary accommodating intraocular lens. Early clinical data shows patients achieving functional vision without glasses complications.
October 8, 2025 — Oncotelic's Sapu003 injectable Everolimus achieves 100% bioavailability in trials, revolutionizing breast cancer treatment with Deciparticles™ nanotechnology for faster, more effective results.
October 8, 2025 — Izotropic's IzoView Breast CT System aims to revolutionize cancer detection for women with dense breast tissue, addressing $8B in annual diagnostic costs and improving accuracy in the growing $5.4B imaging market.
October 8, 2025 — Oncotelic Therapeutics announces first clinical trial of intravenous Deciparticle everolimus for breast cancer. Phase 1 study enrolling patients in Australia for novel mTOR inhibitor delivery system.
October 8, 2025 — Ohio State researchers discover why immunotherapy fails in most cancer patients, identifying TexPSR stress pathway. Breakthrough could improve treatment for millions.
October 8, 2025 — Nutriband Chairman presents at Noble Capital Markets conference Oct 2025. Learn about their abuse-deterrent fentanyl patch technology and investment opportunities in transdermal pharmaceuticals.
October 8, 2025 — Dr. Amit Khera receives 2025 American Heart Association Chairman's Award for transformative work in preventive cardiology, including NASA's Astro-CHARM calculator and FH screening research.
October 8, 2025 — ABVC BioPharma receives $70K licensing payment from ForSeeCon for Vitargus®, the world's first biodegradable vitreous substitute. Learn about this breakthrough in retinal surgery technology.
October 8, 2025 — Simflo launches Flosser Y on Kickstarter - an eco-friendly flossing device with quick-change cartridges and biodegradable options. Revolutionize your oral care routine.
October 8, 2025 — Pastor Pretina Hutchinson releases Destiny Blockers memoir, blending mental health expertise with Christian faith to help readers overcome trauma and spiritual barriers.
October 8, 2025 — Rev. Oreste D'Aversa releases "Autism: A Spiritual Perspective" book offering practical tools and spiritual guidance for autism community. Free sample at AutismSpiritualBook.com.
October 7, 2025 — Soligenix announces positive safety review for HyBryte™ in Phase 3 CTCL trial. No safety concerns found, enrollment on track for 2025 update. Potential new treatment for rare cancer.
October 7, 2025 — Quantum BioPharma (NASDAQ: QNTM) transforms biotech with digital integration, Lucid-MS for multiple sclerosis treatment, and unbuzzd beverage portfolio through innovative clinical and commercial approach.
October 7, 2025 — Oragenics partners with Receptor.AI using AI technology to accelerate neurological drug development. Collaboration focuses on optimizing compounds for brain conditions through intranasal delivery.
October 7, 2025 — BioAdaptives launches MyndMed™ cognitive supplement designed to enhance memory, focus & brain performance. Available nationwide through cGMP-certified manufacturing with third-party testing.
October 7, 2025 — HeartBeam's portable ECG device shows strong correlation with traditional 12-lead ECGs in VALID-ECG study. Breakthrough cardiac monitoring technology validated for detecting arrhythmias.
October 7, 2025 — SBC Medical, Japan's largest beauty clinic chain, targets $9.5B market growth by expanding to males and women 30-40. With 259 clinics and $152M cash for acquisitions.
October 7, 2025 — Lund University researchers discover why leukemia cells evade immune system, revealing key mechanism behind immunotherapy failure in AML treatment and opening new therapeutic possibilities.
October 7, 2025 — AXIM Biotechnologies partners with JK Medical to distribute TearScan® ocular diagnostics across 7 Latin American countries, revolutionizing dry eye and allergy diagnosis.
October 7, 2025 — GeoVax Labs CEO David Dodd to present vaccine & cancer therapy pipeline at ROTH Healthcare Conference. Features COVID-19, Mpox vaccines & Gedeptin cancer treatment in Phase 2 trials.